The human immunodeficiency virus type 1 (HIV-1) genome contains 20 exons that are alternatively spliced from 16 splice sites to generate more than 40 different mRNAs, including incompletely spliced and unspliced mRNAs. In contrast to avian retroviral RNA, which has a cis-acting element in gag that negatively regulates splicing (NRS), HIV-1 RNA did not have any NRS sequences in the gag or pol genes detectable by a splicing inhibition assay. However, this assay demonstrated that the HIV-1 first 5 splice site competed with a cellular 5 splice site, suggesting that HIV-1 may have some strong splice sites. To extend this observation, we used a splice site swapping strategy to determine the efficiency of 14 HIV-1 splice sites in human b globin chimeras tested in transient transfection experiments. While the 1st HIV-1 5 splice site used in all spliced transcripts and the 4th 5 splice site used in most of the 2-kb transcripts were efficient, the other splice sites, including all the 3 splice sites, were less efficient, ranging in use from 25 to 60%. We propose that this range of splice site efficiencies contributes to the regulation of alternative splicing of HIV-1 mRNAs. ᭧
INTRODUCTION
polyadenylation, transport to the cytoplasm, and translation. In the case of the simple avian retroviruses, such Retroviral RNA is transcribed from a provirus inteas Rous sarcoma virus (RSV), both the env and the src grated into the host chromosome and processed by cel-3 splice sites are suboptimal, but the single 5 splice lular machinery (reviewed in Coffin, 1990) . The capped site is strong (Berberich and Stoltzfus, 1991; Fu et al. , and polyadenylated retroviral transcript is alternatively 1991; Katz and Skalka, 1990; McNally and Beemon, 1992 ; and incompletely spliced. Mutations that increase splic- Zhang and Stoltzfus, 1995) . Different mechanisms seem ing decrease viral infectivity, suggesting that a balance to be involved in inhibition of splicing at the 3 sites. The of unspliced and spliced transcripts is essential for ret-RSV env pre-mRNA has a suboptimal branchpoint site roviral replication Zhang and Stoltzfus, located at 016 nt relative to the 3 splice site and a 1995). The complex genome of human immunodeficiency suboptimal pyrimidine tract (Fu et al., 1991; , virus type 1 (HIV-1) (reviewed in Cullen, 1991; Felber and 1988; Katz and Skalka, 1990; Bouck et al., 1995) . The src Pavlakis, 1993) includes 20 exons, bounded by 5 5 and 3 splice site also has a nonconsensus pyrimidine tract 11 3 splice sites, which are alternatively spliced to yield (Zhang and Stoltzfus, 1995) . In addition, a src suppressor more than 40 transcripts Muesing et of splicing has been identified more than 70 nucleotides al., 1985; Purcell and Martin, 1993; Robert-Guroff et al., upstream of the 3 splice site (Berberich and Stoltzfus, 1990; Schwartz et al., 1990) . As in the simpler retrovi-1991; McNally and Beemon, 1992) . Splicing is also conruses, the Ç9-kb primary transcript serves as genomic trolled in RSV by a cis-acting RNA sequence in the gag RNA for progeny virions and as mRNA to generate the gene termed the negative regulator of splicing (NRS), Gag and Pol proteins. The Env, Vif, Vpr, and Vpu proteins which decreases splicing at both 3 splice sites (Arrigo are encoded by an Ç4-kb class of partially spliced and Beemon, 1988; Stoltzfus and Fogarty, 1989) . Insertion mRNAs (Garrett et al., 1991; Schwartz et al., 1990) , and of the NRS into heterologous introns inhibits splicing in a multiply-spliced, Ç2-kb class of mRNAs encodes the an orientation-and position-dependent manner in vivo regulatory proteins Tat, Rev, and Nef (Feinberg et al., and in vitro (Arrigo and Beemon, 1988; McNally et al., 1986; Kim et al., 1989 Kim et al., ). 1991 Gontarek et al., 1993) . Thus, multiple cis-acting Maintenance of the proper balance of retroviral sequences and suboptimal 3 splice sites act additively mRNAs requires mechanisms that prevent the RNA from to control splicing of RSV RNA (McNally and Beemon, splicing to completion while still permitting its capping, 1992 ). An additional level of complexity exists in HIV where Felber et al., 1989; ; Malim and cient splice sites from human b globin. A fragment bearing the 5 or 3 splice site was deleted from constructs Cullen, 1993; Malim et al., 1989) . Rev binds to a highly structured RNA sequence, the Rev response element containing the human b globin first intron and replaced with an HIV-1 fragment bearing a 5 or 3 splice site. (RRE), located in the env gene region that is retained in both the unspliced and the partially spliced (4 kb) HIV-1 Nine chimeric plasmids containing 14 HIV-1 splice sites were transfected into 293 cells, and splicing was astranscripts (Cochrane et al., 1989; Hadzopoulou-Cladaras et al., 1989; Hauber et al., 1988; Malim et al., 1989; sayed by RNase protection. We found that the 1st 5 splice site used in all spliced transcripts and the 4th 5 et al., 1988) . Rev regulation requires either inefficient splicing (Chang and Sharp, 1989; Stutz and Rosbash, splice site used in all but one of the 2-kb transcripts were efficiently used; however, the other splice sites were not. 1994; Lu et al., 1990; Hammarskjold et al., 1994) ; elements within gag, pol, and env genes termed cis-acting Thus, a range of splice site efficiencies was observed; we propose that this contributes to splicing regulation of repressive sequences (CRS) (Rosen et al., 1988) ; inhibitory regions (IR) (Maldarelli et al., 1991) ; or inhibitory HIV-1 mRNAs. sequences (Schwartz et al., 1992) or both inefficient splicing and cis-acting repressive sequences. While some MATERIALS AND METHODS workers observe untranslated CRS-containing RNA in the Plasmid constructs cytoplasm in the absence of Rev (Arrigo and Chen, 1991; Cochrane et al., 1991; D'Agostino et al., 1992) , others
Sequences from the gag and pol regions of HIV-1 BH10 (Ratner et al., 1986) were tested for their ability to inhibit found that these RNAs were restricted to the nucleus (Cochrane et al., 1991; Emerman et al., 1989; Hadzopou- splicing using a heterologous assay developed to study splicing inhibition by the RSV NRS (Arrigo and Beemon, lou- Maldarelli et al., 1991; Cullen, 1993). 1988; McNally et al., 1991) . HIV-1 fragments containing IR-1 (BH10 nt 709-2003, where 1 corresponds to the To investigate the regulation of alternative splicing in HIV-1, we first asked whether cis-acting sequences analbeginning of the U3 long terminal repeat (LTR) sequence), IR-2 (BH10 nt 2008-3859), and CP490 (BH10 nt ogous to the RSV NRS element were present in HIV-1 RNA. Sequences in the gag and pol genes of HIV-1 were 4192-4685) were cloned into a BstXI site within the myc intron of pRSVNeo-int (Linial, 1987 ) to generate pNeotested for splicing inhibition using a heterologous c-myc intron splicing assay previously employed to characterize mycIR1, pNeomycIR2, and pNeomycCP490. Additional constructs were made using subfragments of IR-1: pNeothe RSV NRS element (Arrigo and Beemon, 1988; McNally et al., 1991 ). An HIV-1 gag gene fragment containing a myc3IR1, (BH10 nt and pNeomyc5IR1(BH10 nt 708-840). The NRS was contained in an MroI-SphI CRS element (IR-1) appeared to inhibit splicing as well as the NRS; however, the sequences responsible for (RSV nt 706-1006) fragment in pNeomyc(B)MS (McNally et al., 1991) . splicing inhibition by IR-1 mapped to a small 5 fragment containing the first HIV-1 5 splice site. Unlike the RSV pRSV2Hb was constructed by insertion of the HindIIIBamHI fragment of plasmid SP64 108 containing the first NRS which inhibits splicing of the intron it occupies, the HIV-1 first 5 splice site within IR-1 competed for splicing and second exons and the intervening intron of human b globin (Reed, 1989 ; kindly provided by R. Reed) into with the myc 5 splice site.
Having found that the first HIV-1 splice site was capathe HindIII and BamHI sites of pRSV2 (McNally et al., 1991) . Transcription of this plasmid initiates in the RSV ble of competing with a cellular splice site, we proceeded to investigate the efficiency of the other HIV-1 splice LTR and is terminated by the simian virus 40 (SV40) early poly(A) site. sites. Previous studies of the efficiency of HIV-1 splice sites have involved only a fraction of the 16 identified pHIVHb 5 splice site plasmids. The NcoI-XhoI region of pRSV2Hb was deleted to remove the human b globin HIV-1 splice sites. Several groups have studied the pair of splice sites involved in removal of the second intron 5 splice site, together with 94 nt of exon 1 and 77 nt of adjacent intron sequence. Fragments of HIV-1 BH10 of the 2-kb tat/rev mRNAs (Chang and Sharp, 1989; Krainer et al., 1990; Staffa and Cochrane, 1994) , as well sequence containing 5 splice sites were excised from plasmids pSVGagPol-RRE-R, pSVSX1, or pBH10-flop as the cluster of alternative 3 splice sites used to generate tat, rev, nef, or vpu/env mRNAs (Amendt et al., 1994; Rekosh et al., 1988 ; all kindly provided by M. L. Hammarskjold). Riggs et al., 1994) . However, no global functional comparisons have been made between all of the HIV-1 splice After the ends of these fragments were repaired, they were inserted into pRSV2Hb DNcoI-XhoI to construct sites.
In this study, we investigated the control of alternative the following plasmids: pHIV1Hb, containing the first HIV-1 5 splice site at nt 740 upstream of the gag gene splicing in HIV-1, using a splice site swapping strategy to compare the efficiency of 14 HIV-1 splice sites in chimin the BssHII-XmnI fragment of pSVGagPol-RRE-R (BH10 nt 709-839); pHIV2Hb, containing the second 5 splice eric substrates. Individual 5 and 3 HIV-1 splice sites and flanking sequences, as well as two clusters of 3 site at nt 4995 in the AvaII-NdeI fragment of pSVGagPol-RRE-R (BH10 nt 4971-5158); pHIV3Hb, containing the splice sites, were tested in vivo in combination with effi-third 5 splice site at nt 5486 in the StuI-EcoRI frag-3 splice site probe template was made by inserting a 332-bp AflII-PstI fragment from pRSVNeo-int, which ment of pSVGagPol-RRE-R (BH10 nt 5440-5780); and pHIV5Hb, containing the 4th 5 splice site at nt 6078 spans the myc 3 splice site, into the SmaI site of pGEM-4Z (Promega). Transcription of the HindIII-cut plasmid in the BsmAI-NdeI fragment of pSVSX1 (BH10 nt 6022-6437).
with T7 RNA polymerase yielded a 396-nt probe that protected bands of 332 and 186 nt, corresponding to pHbHIV 3 splice site plasmids. The human b globin 3 splice site, together with 53 nt of intronic sequence unspliced and spliced RNA, respectively. The HIV-1 first 5 splice site probe template was constructed by inserand 119 nt of exon 2 sequence, was removed from pRSV2Hb by deleting the XhoI-DraIII fragment. HIV-1 tion of a 130-nt BssHII-XmnI blunted fragment into pGEM-3Z after the ends were repaired. This plasmid was BH10 fragments bearing 3 splice sites were blunted and inserted into pRSV2Hb DXhoI-DraIII to construct the cut with HindIII and transcribed with T7 RNA polymerase to generate a 191-nt antisense riboprobe. After hybridizafollowing plasmids: pHbHIV2, containing the 3 splice site of exon 2 at nt 4945 in fragment EcoRI-AvaII of tion, a 131-nt unspliced and a 32-nt spliced RNA were visualized on a 12% polyacrylamide-8 M urea sequencpSVGagPol-RRE-R (BH10 nt 4682-4974); pHbHIV3, containing the 3 splice site of exon 3 at nt 5422 in the NdeIing gel. Analysis of globin-HIV chimeric transcripts was carStuI fragment of pSVGagPol-RRE-R (BH10 nt 5156-5440); pHbHIV4, containing the 3 splice site of exon 4 at nt ried out by hybridization to an anti-sense transcript of pHb2, constructed by insertion of the HindIII-BamHI 5810 in the StuI-EcoNI (DAvrII-AvrII) fragment of pSVGagPol-RRE-R (BH10 nt 5438-5825, D5464-5694); fragment of human b globin into the EcoRI-BamHI sites of pGEM-4Z. pHb2 was linearized by digestion with HinpHbHIV4c-5, containing the 3 splice sites of exons 4c, 4a, 4b, and 5 at nt 5969, 5987, 5993, and 6010, respecdIII and transcribed with SP6 to generate a riboprobe which spanned the human b globin exon 1-intron 1-tively, in the SalI-HinfI fragment of pBH10-flop (BH10 nt 5819-6052); and pHbHIV7, containing the 3 splice sites exon 2 region, allowing for the simultaneous detection of unspliced and spliced RNAs at both the 5 and the 3 of exons 7, 7a, and 7b at nt 8380, 8384, and 8408 in the HindIII-BamHI fragment of pSVSX1 (BH10 nt human b globin splice sites. A second riboprobe, pMyc2-3DSal (McNally et al., 1991) , was synthesized to detect 8172-8509).
expression of the transfection control plasmid, pMyc23. Cell culture and transfection RESULTS The 293 cells, human embryonic kidney cells transformed by human adenovirus type 5 (kindly provided by CRS elements do not affect RNA splicing G. Ketner), were maintained in minimum essential meUnlike viral unspliced RNAs, the unspliced RNAs from dium with 10% fetal calf serum and penicillin-streptomyheterologous genes containing the RSV NRS in the intron cin. Cells on a 6-cm dish were transfected with 5 mg are restricted to the nucleus where they accumulate to plasmid DNA by the calcium phosphate method (Prohigh levels (Arrigo and Beemon, 1988) . This is similar to mega). To assay for transfection efficiency, the cells were the nuclear retention observed with the HIV-1 cis-acting cotransfected with a second plasmid, pMyc23 (McNally repressive elements and suggested that the RSV and et al., 1991) . Expression of the test plasmids and the HIV-1 elements may have similar or overlapping activimyc plasmids was assayed simultaneously by RNase ties. To test this, CRS elements from the HIV-1 gag and protection with different riboprobes.
pol genes were tested for splicing inhibition using a heterologous intron splicing assay previously employed to RNA isolation and mapping characterize the RSV NRS element (Arrigo and Beemon, 1988; McNally et al., 1991) . Total cellular RNA was isolated 48 hr after transfection with RNAzol (Chomczynski and Sacchi, 1987 ; Cinna/BioThree different previously characterized HIV-1 CRS elements (IR-1, IR-2, and CP490) (Maldarelli et al., 1991; tecx) . Hybridization and RNase protection were performed as described previously (Arrigo and Beemon, Cochrane et al., 1991) were inserted into the myc intron of pRSVNeo-int (Linial, 1987) at a position 163 nt down-1988; McNally et al., 1991; Melton et al., 1984) using probes described below. A PhosphorImager (Molecular stream from the 5 splice site (Fig. 1A ). After transfection of these constructs into 293 cells, the relative amounts Dynamics) or InstantImager (Packard) was used to quantify RNA levels, in most cases on 6% polyacrylamideof spliced and unspliced RNA transcripts were determined by RNase protection assays, using a probe span-8 M urea sequencing gels (Maxam and Gilbert, 1980) . Adjustments were made for the size and base composining the myc 5 splice site (Fig. 1A) . We observed that control constructs containing no intronic insert produced tion of the respective fragments, when the percentage of spliced transcripts was calculated.
less than 5% unspliced RNA, whereas constructs containing the RSV NRS at this position produced approxiRiboprobes for analysis of the myc-CRS constructs included the pRSVNeo-int myc 5 splice site probe, which mately 95% unspliced RNA (Fig. 1B) . Similar results were previously obtained when these constructs were was described previously (McNally et al., 1991) . The myc or CP490 inserted into the myc intron (Fig. 1B) . However, levels of unspliced RNA comparable to that generated with the NRS were seen when IR-1 was present (Fig. 1B) . Control constructs containing these same inserts in the anti-sense orientation were also tested; none of these showed an increase in unspliced RNA levels (data not shown).
To localize the sequences within IR-1 that mediated splicing inhibition, we tested subfragments of IR-1 in the myc splicing assay. Using the myc 5 splice site probe, we found that a 132-nt fragment from the 5 end of IR-1 was as active at inhibiting myc splicing as was either the entire 1295-nt IR-1 element or the RSV NRS ( Fig. 2A) . No inhibition of splicing was seen with a 1163-nt fragment derived from the 3 portion of IR-1 (Fig. 2A) . This 5 IR-1 fragment contains the HIV-1 first 5 splice site that is used in all spliced HIV-1 transcripts, raising the possibility that the decreased splicing observed from the myc 5 splice site may have resulted from competition between the myc and the HIV-1 5 splice sites rather than from the presence of a cis-acting inhibitory element like the NRS. Since the initial RNase protection assays (Figs. 1B, and 2A) were carried out with a myc 5 splice site probe, it was not possible to distinguish between these possibilities. Any splicing of transcripts from the HIV 5 splice site to the myc 3 splice site would appear as unspliced RNA using the myc 5 splice site probe, which is upstream of the HIV-1 insert.
Competition between the myc 5 splice site and the HIV 5 splice site within IR-1
To determine if the unspliced RNA observed in the presence of IR-1 resulted from splicing inhibition or competition between the myc 5 splice site and the site in IR-1, additional RNase protection assays were performed using probes for both myc 5 and myc 3 splice sites and for the HIV-1 5 splice site. If splicing were inhibited, a Cochrane et al. (1991) . Each of HIV-1 5 splice site would result in higher levels of fully the CRS elements was inserted into the myc intron of the pRSVNeoprotected probe (apparent unspliced RNA) using the myc int construct (Linial, 1987) was tested by RNase protection analysis with a probe these splice sites to one another, a set of chimeric constructs containing 14 HIV-1 splice sites paired with huspecific for the HIV-1 first 5 splice site; this probe showed high levels of spliced RNA with both the IR1 and man b globin splice sites was generated, and the splicing efficiencies of these constructs were compared in the 5IR1 constructs (Fig. 2C ). In conclusion, none of the three CRS elements tested inhibited splicing, and the transfected cells. The nucleotide positions of the HIV-1 BH10 splice sites first HIV 5 splice site competed efficiently with the myc 5 splice site in these constructs.
were determined by comparison of the BH10 sequence (Ratner et al., 1986) to that of HIV-1 HXB2 splice sites (Schwartz et al., 1990 (Schwartz et al., , 1991 and to the splice sites of Fourteen HIV-1 splice sites assayed in chimeric pNL4-3 in the case of 3 splice site 4c (Purcell and Martin, constructs 1993) . In all cases, the BH10 splice junctions were identiThe HIV-1 genome contains 20 exons, which are altercal in sequence to those of HXB2. Table 1 displays a natively spliced using 16 splice sites, shown in Fig. 3, to comparison of the HIV-1 BH10 splice site sequences to generate more than 40 different transcripts (Felber et al., consensus splice sites (Senapathy et al., 1990) . While all 1990; Muesing et al., 1985; Purcell and Martin, 1993;  of the 5 splice sites match the consensus sequence by Robert-Guroff et al., 1990; Schwartz et al., 1990) . To ex-6 to 8 of 9 nucleotides, none of the 3 splice sites are tend the observation that the first HIV-1 5 splice site is good matches to the consensus because their pyrimidine very strong (Fig. 2C) , we investigated the relative tracts are very short and interrupted by purines. Since none of the HIV-1 branchpoints have been identified exstrengths of the other HIV-1 splice sites. To compare and pNL4-3 (Purcell and Martin, 1993; Schwartz et al., 1990 Schwartz et al., , 1991 . The locations of the 5 splice sites are indicated above and of the 3 splice sites below the diagram. 5 splice site 5 is used by multiple exons, containing 3 splice sites 3-5.
perimentally and these can be as far as 100 nt upstream and intron and most of the second exon (Reed, 1989) into the pRSV2 expression vector (McNally et al., 1991) , of the 3 splice sites (reviewed in Smith et al., 1989) , we have not tried to match putative branchpoints to the so that transcription of this plasmid initiates in the RSV long terminal repeat and is terminated by the SV40 early branch consensus sequence.
To examine the efficiency of individual HIV-1 splice polyadenylation signal (lacking any SV40 intron). The sites in vivo, a splice site swapping strategy was used second b globin exon was truncated at its 3 end by 14 in which a fragment containing a 5 or 3 HIV-1 splice nt in this construct to avoid the inclusion of the 5 splice site was paired with an efficient splice site from human site of exon 2 upstream of the polyadenylation site; this b globin. The parental b globin construct, pRSV2Hb, has been shown to interfere with the definition of the shown in Fig. 4 , was constructed by the insertion of huultimate exon and polyadenylation in other constructs man b globin sequence spanning the entire first exon assayed in vivo (Niwa et al., 1992) . To generate chimeric splicing substrates, a fragment containing the 5 or 3 splice site of human b globin was deleted from pRSV2Hb and an HIV-1 fragment bearing
Comparison of HIV-1 BH10 Splice Site Sequences with Consensus a 5 or 3 splice site was inserted in its place (Fig. 4) . numbers of the splice sites shown in Fig. 3B . pHbHIV2
total RNA was isolated 48 hr after transfection. RNase protection assays were performed using an anti-sense riboprobe that was complementary to human b globin exons 1 and 2, as well as the intervening intron 1, allowing unspliced and spliced transcripts using either splice site to be distinguished by gel electrophoresis (Figs. 5 and 6). Thus, this same probe could be used to assay the splicing efficiency of all nine chimeras, allowing direct comparisons between them without variations due to the use of different probes. Multiple transfection experiments were performed, and the splicing level of each construct was quantified. Table 2 displays the average percentage of spliced RNA obtained with each construct.
The HIV-1 5 splice sites of exons 1 and 5 are used efficiently
The transcripts generated by the control plasmid, pRSV2Hb, were spliced quite efficiently (89 { 12% spliced) as expected (Fig. 6, Table 2 ). However, the HIV1Hb transcript bearing the first HIV-1 5 splice site, upstream of the gag coding region, was spliced even more efficiently (95 { 4% spliced) than the human b globin first 5 splice site. We have observed similar results with a second HIV1Hb construct containing 264 nt of additional HIV-1 exonic sequence upstream of the 5 (Fig. 2C) . In that experiment, different pRSV2Hb and replaced with a 3 splice site from HIV.
amounts of HIV-1 downstream intronic sequence (100 to 1263 nt) in constructs 5IR1 and IR1 did not affect usage of this 5 splice site, suggesting that neither upstream and pHbHIV3 include sequences bearing the 3 splice sites of exons 2 and 3, respectively. The fragment cloned nor downstream sequences regulate its activity. This splice site, which is used in all the spliced mRNAs, exhibinto the pHbHIV4 plasmid contains the 3 splice site of exon 4. The plasmid pHbHIV4c-5 includes the 3 splice its the closest match to a consensus 5 splice site (8/9 nt, including all of the intronic nt) of all the HIV-1 splice sites of exons 4c, 4a, 4b, and 5 that are clustered within a 41-nt region. Because 3 splice sites include significant sites (Table 1) . The presence of an efficient first 5 splice site in HIV-1 reiterates the finding of a strong 5 splice upstream intronic sequence (branchpoint and pyrimidine tracts) which would overlap with these splice sites, it site in avian retroviruses (Katz and Skalka, 1990; McNally and Beemon, 1992) . was not possible to separate them. For the same reason, three 3 splice sites, 7, 7a, and 7b, that are clustered
The 5 splice site in pHIV5Hb, which is used in multiple mRNAs to remove the intron nearest the 3 end of the within a 28-nt region, were cloned into pHbHIV7. Because exon 6D is used infrequently (Benko et al., 1990;  RNA to generate the 2-kb class of HIV-1 mRNAs (tat, rev, nef) , was 83 { 10% spliced (Fig. 6, Table 2 ). It may be Purcell and Martin, 1993), we chose not to investigate its splice sites. Since none of the HIV-1 branchpoints significant that this splice site is not as strong as the first 5 splice site, since many HIV-1 mRNAs are singly have been mapped, enough intronic sequence (ú100 nt) was included in the HIV-1 3 splice site constructs to spliced, and all of these have spliced out only the first intron. Thus, the 4-kb class of HIV-1 mRNAs all use the contain any distant branchpoints.
To analyze the splicing efficiency of the chimeric HIVfirst 5 splice site and do not use the second major 5 splice site at nt 6078. The HIV-1 5 splice sites 2 (38 { 1/human b globin transcripts in vivo, the constructs were transfected into 293 cells with calcium phosphate, and 11% spliced) and 3 (45 { 6% spliced) of exons 2 and 3, which are present in the 2-kb transcripts as optional, DISCUSSION upstream, noncoding exons, were less efficiently used
The HIV-1 primary RNA transcript is used in its unin the hybrid transcripts than were the 5 splice sites spliced form as mRNA and genomic RNA; it is also a 1 or 5.
pre-mRNA that is alternatively spliced to generate more than 40 different mRNAs. As an initial step in dissecting All the HIV-1 3 splice sites are suboptimal the mechanisms involved in this very complex splicing pathway, we have compared the relative efficiencies of The levels of splicing observed with the HIV-1 3 splice site chimeric constructs were also variable (Fig. 6 , Table the HIV-1 splice sites in the absence of viral proteins and have searched for cis-acting splicing regulatory se-2). The 3 splice site 2 was the least efficiently used of all the splice sites (26 { 16% spliced). Splicing to this quences in the HIV-1 gag and pol genes. In contrast to previous conclusions that HIV-1 splice sites are suboptisite is necessary to generate the 4-kb vif mRNA. Exon 2, bordered by 3 splice site 2 and 5 splice site 2, is also mal, based on analysis of a subset of these splice sites, we have observed that the first 5 splice site is very present as a noncoding exon in many 2-kb mRNAs. A higher level of spliced RNA was obtained with 3 splice strong in several different contexts. Further, the 5 splice site used to generate the 2-kb mRNAs is relatively strong, site 3 (60 { 10% spliced), which is used to generate the 4-kb vpr mRNA and is also used, in conjunction with 5 but weaker than the first 5 splice site. However, all of the 3 splice sites are suboptimal (õ60% splicing); thus, splice site 3, as an optional, noncoding exon of the 2-kb mRNAs. HbHIV4 RNA, containing the first tat 3 slice site, there are no strong pairs of splice sites in HIV-1 premRNA. Comparison of the relative strengths of splice was spliced at an intermediate level (55 { 11% spliced). Despite bearing multiple 3 splice sites from exons 4c, sites of HIV-1 and RSV RNAs showed striking similarities, in that both have strong 5 splice sites and weaker 3 4a, 4b, and 5 (for rev, nef, env, and vpu), pHbHIV4c-5 transcripts (48 { 11% spliced) were spliced with slightly splice sites (Fig. 7) .
Comparison of the relative efficiencies of 14 HIV-1 lower efficiency. The level of splicing obtained with pHbHIV7 transcripts, which contain the 3 splice sites of splice sites in globin chimeric constructs showed considerable variation. Transcripts containing HIV-1 5 splice tat, rev, and nef 3-terminal exons, was even lower (41 { 11% unspliced). Since HbHIV7 contains three alternasites ranged from 38 to 95% spliced, while the HIV-1 3 splice site transcripts varied from 26 to 60% spliced. We tive 3 splice sites (7, 7a, and 7b) but only use of splice site 7 results in functional mRNAs (Schwartz et al., 1990), propose that this inherent variability in the efficiency of the HIV-1 splice sites contributes to the control of alternathe level of splicing to 7 is lowered due to competition between these three splice sites, which are present in tive splicing in HIV-1. In most cases, the efficiency of use of a splice site in the chimeric transcript correlated with a 28-nt region. In contrast to the HIV-1 5 splice sites, none of the 3 splice sites yielded more than 60% spliced that splice site's usage in HIV-infected cells, as determined by the relative abundance of transcripts containing RNA. Therefore, in HIV-1 there are no possible combinations of strong 5 and 3 splice sites that can be used that splice site (Guatelli et al., 1990; Purcell and Martin, 1993; Robert-Guroff et al., 1990). The most efficient splice together. -7) ; or with 3 HIV splice site constructs, pHbHIV (lanes 9-13), using the Hb2 riboprobe to distinguish unspliced from spliced RNA. Lane 1 contains the b globin riboprobe. The b globin riboprobe protected two spliced bands representing both exons of pRSV2Hb (lane 3) and is therefore a control for both HIVHb and HbHIV splicing. Multiple-spliced bands, all of which were quantified together, were observed with all of the HbHIV transcripts (lanes 9-13) and also with the globin control (lane 3). The amount of total RNA recovered after RNase protection with construct HIV2Hb (lane 5) was reproducibly less than with the other constructs, possibly due to instability of this chimeric RNA. The band showing the control for transfection efficiency was cut off of the bottom of this gel. From the top of the gel, the sizes of the HpaII DNA marker bands are 622, 527, 404, 309, 242, 238, 217, 180, 160, and 123 nt (lane 2). site, the first 5 splice site, is used in all spliced tranducibly lower than the others. This may reflect differences in the stability of the transcripts. If degradation scripts. The second most efficient was the 5 splice site used in all of the 2-kb transcripts encoding Tat, Rev, and occurs prior to splicing or affects spliced and unspliced transcripts similarly, this would have no effect on the Nef. The 3 splice sites of exon 7, also used in these 2-kb transcripts, were less efficiently used than the 5 levels of splicing observed. However, a difference in the stability of the spliced and unspliced transcripts would splice site, consistent with previous studies (Chang and Sharp, 1989; Staffa and Cochrane, 1994) . The infrequently alter the interpretation of splicing levels. Additional work is needed to determine the relative stabilities of HIV-1 used exons 2 and 3 had relatively weak splice sites; these exons had the poorest 5 splice sites, and exon 2 mRNAs. It is interesting that Rev has been observed to increase the stability of incompletely spliced RRE-bearalso had the poorest 3 splice site (26% spliced), in contrast exon 3 had a relatively strong 3 splice site (60% ing HIV-1 transcripts Malim and Cullen, 1993 ). spliced).
Some variation in total RNA levels was observed beAs in the simple avian retroviruses previously studied (Katz and McNally and Beemon, 1992) , the tween the different chimeric transcripts shown in Fig. 6 . In particular, the level of HIV2Hb transcripts was repro-5 splice site nearest the 5 end of HIV-1 RNA was highly et al., 1994) , which is not present in our pHbHIV4 construct. The 3 splice sites of exons 4a, 4c, 4b, and 5 efficient (Fig. 7) . The importance of a strong first 5 splice could not be separated since they are clustered within site for viral replication is supported by the observation a 41-nt region; together they spliced at 48%. Splicing of Purcell and Martin (1993) that mutation of this splice at the individual sites within this cluster must represent site leads to activation of a cryptic site 4 nt downstream a fraction of the composite we have measured. It would in a sequence highly conserved among HIV-1 isolates.
be of interest to map the branchpoints involved in HIVSince all spliced HIV-1 mRNAs (both 4-and 2-kb classes) 1 RNA splicing, particularly those involving this cluster use the first 5 splice site, it is not surprising that this is of four 3 splice sites. It is possible that some of these a strong splice site; otherwise aberrantly spliced mRNAs splice sites may share branchpoints or pyrimidine retaining the first intron might be generated. Further, the tracts. Temporal analysis of alternative splicing of the presence of alternative weak 3 splice sites that pair with competing 3 splice sites in the transcripts encoding a single strong 5 splice site allows multiple mRNAs to the regulatory proteins Tat and Rev revealed that the be generated by competition between these 3 splice relative levels of these transcripts remained constant sites. Work of Hammarskjold and coworkers (Hammarthroughout viral replication, suggesting that alternative skjold et Lu et al., 1990 ) also suggests that the splicing was not being regulated by trans-acting viral or cellular factors but by cis-acting splice site preferpresence of an active 5 splice site may be necessary , 1992) . The RSV major 5 splice site is 88% spliced, the env 3 splice site is 62% spliced, and the src 3 splice site is 47% spliced; thus in both HIV-1 and RSV, the major 5 splice site was strong while the 3 splice sites were weaker.
ences (Guatelli et al., 1990) . The existence of variable gesting regulatory elements may not be present in the vicinity of the strong, first 5 splice site of HIV-1 RNA. splice site efficiencies would be consistent with this.
Unlike the simple retroviruses, HIV-1 encodes a reguIn the avian retroviruses, splicing is regulated both by latory protein, Rev, necessary for productive expression suboptimal splice sites and by cis-acting elements (Katz of unspliced and partially spliced viral transcripts in the and McNally and Beemon, 1992; Zhang cytoplasm (Emerman et al., 1989; Felber et al., 1989; and Stoltzfus, 1995) . In RSV, an intronic sequence in the Malim et al., 1989) . Multiple gag gene, the NRS, inhibits splicing (Arrigo and Beemon, functions have been demonstrated for Rev including inhi-1988; Gontarek et al., 1993; McNally et al., 1991; bition of splicing Kjems et al., 1992; and Fogarty, 1989) . In this work, analysis of the gag-pol Kjems and Sharp, 1993) , increasing RNA stability (Feinregion of HIV-1 did not reveal sequences functionally berg et al., 1986; Felber et al., 1989) , nuclear export (Emanalogous to the NRS. The HIV-1 gag CRS element, IRerman et al., 1989; Felber et al., 1989;  Hammarskjold et 1, appeared initially to be an effective inhibitor of splicing al., 1989; Malim et al., 1989; Fischer et al., 1994) , and from the myc 5 splice site, but the inhibition observed translation (Arrigo and Chen, 1991; Cochrane et al., 1991;  was not from activity similar to that of the NRS but rather D' Agostino et al., 1992) of RRE-containing transcripts. Rev by competition between the HIV and the myc 5 splice regulation of b globin constructs requires a single subopsites. The sequences within the RSV NRS resemble both timal splice site that delays intron removal, suggesting 5 and 3 splice sites, and it has been shown that U1
that Rev may promote the disassociation of splicing comand U2 snRNPs, as well as U11/U12 snRNPs, interact plexes to allow transport of unspliced or incompletely with the NRS (Gontarek et al., 1993) . However, splicing spliced RNA to the cytoplasm (Chang and Sharp, 1989) . has never been observed into or out of the NRS in RSV
We have demonstrated that all HIV-1 introns are flanked constructs, even when the authentic viral 3 splice sites by at least one suboptimal splice site. Despite the preswere deleted to relieve any potential competition (unence of two efficient 5 splice sites, there were no pairs published results). While it is possible that the methods of efficient splice sites in HIV-1 because all the 3 splice used here would not identify all negative elements, it sites were suboptimal. This may be necessary to mainappears that elements capable of acting over a long tain the high level of HIV-1 transcripts that remain undistance, like the NRS, are not present in the gag -pol spliced and to allow the use of all of the alternative 3 region of HIV. splice sites. In vitro studies have shown that a Rev pepWhile variation in efficiency of individual splice sites tide can inhibit splicing of RRE-containing transcripts would contribute to the regulation of alternative splicing (Kjems et al., 1992; Kjems and Sharp, 1993) ; however, in HIV-1, it does not preclude the existence of other levels this has not been observed with Rev-defective constructs of regulation. Although we did not find an intronic, global, studied in vivo (Malim and Cullen, 1993) . While Rev-medicis-acting element in the gag or pol sequence of HIV-1, ated transport of RRE-containing RNA out of the nucleus Amendt et al. (1994) identified a SRE within the first tat will prevent its further splicing, our studies show that coding exon of HIV-1 that acted in a position-and orientasplicing is inefficient even in the absence of Rev. tion-dependent manner to inhibit splicing at the upstream 3 splice site. Deletion of the small element increases ACKNOWLEDGMENTS splicing at the 3 splice site of exon 4 (Amendt et al.,
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siderably more upstream or downstream sequence, sug-
